Ansan-si, South Korea

Si Young Lee


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Si Young Lee: Innovator in Ophthalmic Preparations

Introduction

Si Young Lee is a notable inventor based in Ansan-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized external preparations and ophthalmic formulations. With a total of 3 patents, Lee's work focuses on enhancing the stability and efficacy of therapeutic agents.

Latest Patents

One of Lee's latest patents is titled "Stabilized external preparation comprising thymosin beta 4 as an active ingredient." This invention relates to a therapeutically effective external preparation that improves the stability and biological activity of thymosin beta 4 (Tβ4). The preparation ensures that Tβ4 remains in a stable state while minimizing the generation of Tβ4 sulfoxide through oxidation reactions and multimers through aggregation.

Another significant patent is the "Method for preparing ophthalmic preparation containing thymosin beta-4." This innovative method involves manufacturing an ophthalmic preparation in the presence of an inert gas, which prevents the oxidation of thymosin β4. As a result, the pharmacological activity of thymosin β4 is maintained for an extended period, ensuring the preparation remains effective over time.

Career Highlights

Si Young Lee is currently associated with G-treebnt Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in therapeutic treatments, particularly in ophthalmology.

Collaborations

Lee collaborates with talented individuals in his field, including Kyoungsun Kim and Tae Heum Um. Their combined expertise contributes to the innovative projects at G-treebnt Co., Ltd.

Conclusion

Si Young Lee's contributions to the field of pharmaceuticals, particularly through his patents on thymosin beta 4, highlight his role as a key innovator. His work not only enhances the stability of therapeutic agents but also paves the way for more effective treatments in ophthalmology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…